Interleukin‐1 blockade by anakinra improves clinical symptoms in patients with neonatal‐onset multisystem inflammatory disease
- 7 April 2005
- journal article
- case report
- Published by Wiley in Arthritis & Rheumatism
- Vol. 52 (4) , 1283-1286
- https://doi.org/10.1002/art.20953
Abstract
Neonatal‐onset multisystem inflammatory disease (NOMID) is a rare, childhood‐onset disease that is characterized by chronic, systemic inflammation. The purpose of this report is to describe the effects of interleukin‐1 (IL‐1) blockade on the clinical symptoms of 2 patients with NOMID. At the time of this report, the patients had been treated with anakinra (Kineret), a recombinant human IL‐1 receptor antagonist, for 1.5 and 2 years, respectively. Both patients demonstrated rapid improvement in clinical symptoms and laboratory markers of inflammation. The use of anakinra in these patients seemed to be effective, without any safety concerns. These observations suggest that IL‐1 plays a critical role in the pathogenesis of this inflammatory disease, and that blockade with anakinra should be further studied as a treatment for patients with NOMID and related disorders.Keywords
This publication has 9 references indexed in Scilit:
- Response to anakinra in a de novo case of neonatal‐onset multisystem inflammatory diseaseArthritis & Rheumatism, 2004
- Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCUBlood, 2004
- Spectrum of clinical features in Muckle‐Wells syndrome and response to anakinraArthritis & Rheumatism, 2004
- Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle CellsCirculation, 2003
- Interleukin-1–Receptor Antagonist in the Muckle–Wells SyndromeNew England Journal of Medicine, 2003
- The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestationsCurrent Opinion in Rheumatology, 2003
- De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal‐onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin‐associated autoinflammatory diseasesArthritis & Rheumatism, 2002
- Chronic Infantile Neurological Cutaneous and Articular Syndrome Is Caused by Mutations in CIAS1, a Gene Highly Expressed in Polymorphonuclear Cells and ChondrocytesAmerican Journal of Human Genetics, 2002
- Cytokines and the Hepatic Acute-Phase ResponseSeminars in Liver Disease, 1999